Comment on Retnakaran et al. Liraglutide and the preservation of pancreatic β-cell function in early type 2 diabetes: the LIBRA trial. Diabetes Care 2014;37:3270-3278

Diabetes Care. 2015 Feb;38(2):e25. doi: 10.2337/dc14-2418.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Cytoprotection*
  • Diabetes Mellitus, Type 2 / drug therapy*
  • Female
  • Glucagon-Like Peptide 1 / analogs & derivatives*
  • Humans
  • Hypoglycemic Agents / therapeutic use*
  • Insulin-Secreting Cells / drug effects*
  • Male

Substances

  • Hypoglycemic Agents
  • Glucagon-Like Peptide 1